Drugs

Acknowledgement
pp. 2519-2521(3)

Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses
pp. 2523-2531(9)
Authors: Hurt, Aeron C.; Holien, Jessica K.; Parker, Michael W.; Barr, Ian G.

New Pharmacological Developments in the Treatment of Hepatocellular Cancer
pp. 2533-2540(8)
Authors: Gusani, Niraj J.; Jiang, Yixing; Kimchi, Eric T.; Staveley-O'Carroll, Kevin F.; Cheng, Hua; Ajani, Jaffer A.

Treatment of Allergic Rhinitis in Infants and Children: Efficacy and Safety of Second-Generation Antihistamines and the Leukotriene Receptor Antagonist Montelukast
pp. 2541-2576(36)
Authors: Phan, Hanna; Moeller, Matthew L.; Nahata, Milap C.

Bacterial Meningitis: Epidemiology, Pathogenesis and Management Update
pp. 2577-2596(20)
Authors: Nudelman, Yuliya; Tunkel, Allan R.

Transdermal Granisetron
pp. 2597-2605(9)
Authors: Duggan, Sean T.; Curran, Monique P.

Telavancin
pp. 2607-2620(14)
Authors: Lyseng-Williamson, Katherine A.; Blick, Stephanie K.A.

Topical Diclofenac Solution
pp. 2621-2632(12)
Author: Moen, Marit D.

Peginterferon-α-2a (40 kD): A Review of its Use in Chronic Hepatitis B
pp. 2633-2660(28)
Author: Keating, Gillian M.